An Open-Label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT).
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2014
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms SPRINT
- Sponsors The Medicines Company
- 30 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jan 2009 Status changed from not yet recruiting to recruiting.